To avoid the confounding effect of SOX2 gene amplification in squamous cell carcinoma (SCC), and to focus on tumors with demonstrated involvement of NFATc2, we performed IHC analysis on 92 moderately to poorly differentiated AD. This evidence concerns the gene SOX2 and Alzheimer disease.